Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma

NCT00713687 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped recruiting failed

Conditions

Cholangiocarcinoma

Interventions

DRUG: Gemcitabine, Oxaliplatin, Photodynamic therapy (Photosan®)

Sponsor

Technical University of Munich

Collaborators

[object Object]